NCT04052191View on ClinicalTrials.gov

MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

December 1, 2026

Conditions

Coronary Artery Disease

Interventions

BIOLOGICAL

MCRcI® stem cells

Intra-Coronary Administration of MCRcI® stem cells

Trial Locations (1)

74147

HONYA Medical Inc, Tainan City

Sponsors

Lead Sponsor

Honya Medical Inc

All Listed Sponsors

collaborator

Chang Gung Memorial Hospital

OTHER

lead

Honya Medical Inc

INDUSTRY